ex.VAT:
VAT:
inc.VAT:

Discover the program!
Wednesday, March 6, 2019Congresses

Endocrine disruptors explained by the FEBEA (3/3)

Atelier presse de la FEBEA sur les perturbateurs endocriniens

The issue of endocrine disruption is a real public health issue, which political and health authorities have begun to consider as such. But pending the concrete results of the various action plans undertaken, should consumers fear the identified or suspected “endocrine disrupting substances” in their daily products, and in particular their cosmetics? During the press workshop organised by FEBEA on 14 February 2019, Anne Dux, Director of Scientific and Regulatory Affairs, and Françoise Audebert, Scientific and Regulatory Advisor, were reassuring.

Reading time
~ 8 minutes

This content is only available to subscribersPRO, PREMIUM, STARTUP and TPE

Already subscribed?Log in

Discover our subscriptions


Associated elements(2)

Luxepack Monaco 2022 edition

CongressesOther articles

609results